Concepedia

Author

Yasmina Amraoui

Johannes Gutenberg University MainzORCID

Also Known As

Y. El Amraoui, Yasmina Amraoui, Yasmina Amraoui (670326)

37

Publications

705

Citations

13

H-Index

29

Concepts

All Affiliations

Johannes Gutenberg University MainzUniversity Medical Center of the Johannes Gutenberg University MainzRigshospitaletCopenhagen University HospitalChildren's Memorial Health Institute
YA

About

Yasmina Amraoui is an author at Johannes Gutenberg University Mainz specializing in neuropathology, medicine, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

242

2

Natural Sciences

2

2

176

3

Biochemistry

2

2

176

4

Cell Biology

1

1

83

5

Medical Laboratory Science

1

1

83

Yasmina Amraoui

×

14

Publications

686

Citations

13

H-Index

YearCitations

Acetyl- <scp>dl</scp> -leucine in Niemann-Pick type C

Tatiana Brémovà-Ertl, Vĕra Malinová, Yasmina Amraoui,

Neurology

2015

100

Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators

Miriam Stampfer, Yasmina Amraoui, Xuntian Jiang,

Orphanet Journal of Rare Diseases

2013

98

Plasma Lysosphingomyelin Demonstrates Great Potential as a Diagnostic Biomarker for Niemann-Pick Disease Type C in a Retrospective Study

Richard W.D. Welford, Marco Garzotti, Charles Marques Lourenço,

PLoS ONE

2014

93

Relative acidic compartment volume as a lysosomal storage disorder–associated biomarker

Daniëlle te Vruchte, Anneliese O. Speak, Kerri L. Wallom,

Journal of Clinical Investigation

2014

83

Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation

Line Borgwardt, Hilde Monica Frostad Riise Stensland, Klaus J Olsen,

Orphanet Journal of Rare Diseases

2015

59

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐blind, randomised, placebo‐controlled trial

Line Borgwardt, Nathalie Guffon, Yasmina Amraoui,

Journal of Inherited Metabolic Disease

2018

59

Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis

Allan M. Lund, Line Borgwardt, Federica Cattaneo,

Journal of Inherited Metabolic Disease

2018

55

The Clinical and Molecular Spectrum of GM1 Gangliosidosis

Laila Arash‐Kaps, Katalin Komlósi, Marlene Seegräber,

The Journal of Pediatrics

2019

35

Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann–Pick disease type C in a retrospective study

Richard W.D. Welford, Marco Garzotti, Charles Marques Lourenço,

Molecular Genetics and Metabolism

2015

31

Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients

Richard W.D. Welford, Hervé Farine, Michel A. Steiner,

Molecular Genetics and Metabolism Reports

2022

22

Page 1